SOURCE: Brighton Markets

February 27, 2012 09:00 ET

2012 Economic Outlook - Report Highlights Ariad Pharmaceuticals, Inc. and Opko Health Inc.

HONG KONG--(Marketwire - Feb 27, 2012) - Today, www.BrightonMarkets.com announced new reports highlighting Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) and Opko Health Inc. (NYSE: OPK). Gain market insight with full analysis and research downloads available at www.BrightonMarkets.com/index.php?coa=ARIA&cob=OPK.

Economic fundamentals leading into 2012 have set a generally positive pace with GDP growth likely to pick up through the coming year. However, there are several important caveats to note as the world economy continues to face headwinds and risks weigh to the downside. Positive outlooks are conditional on fiscal policy in payroll taxes and unemployment insurance benefits and upon the easing of the European debt situation. A repeat of volatility experience in 2011 is likely in 2012, as perceptions about the strength of the U.S. economy and the euro zone will vary over time as events unfold.

Despite the current situation, our team continues to identify high momentum situations with growth potential -- there remains strong opportunity within careful discretion.

Brighton Markets is releasing new coverage on Ariad Pharmaceuticals, Inc. for its current position within the healthcare industry. ARIAD Pharmaceuticals, Inc. (ARIAD) is a biopharmaceutical company focused on the discovery and development of drugs to provide therapeutic intervention in treating human diseases at the cellular level. As of December 31, 2010, the Company's pipeline of product candidates included three compounds, such as ridaforolimus, ponatinib and AP26113. The full research report on Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) is available here: www.BrightonMarkets.com/index.php?coa=ARIA.

Brighton Markets has released research on Opko Health Inc. for its changing role within the healthcare industry. OPKO Health, Inc., is a pharmaceutical and diagnostics company. It is focused on developing a range of solutions, including molecular diagnostics tests, pharmaceuticals and vaccines. It operates in two segments: pharmaceutical and instrumentation segments. The full research report on Opko Health Inc. (NYSE: OPK) is available here: www.BrightonMarkets.com/index.php?cob=OPK.

About Brighton Markets
Brighton Markets was founded on the guiding principle of providing highly relevant, meaningful, and actionable information direct to investors. Across the investment spectrum, Brighton Markets shines light on today's events.

Contact Information